Compounds > 1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)
Page last updated: 2024-08-24

1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) and r-82913

1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) has been researched along with r-82913 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, E; Boyer, PL; Ding, J; Hughes, SH1

Other Studies

1 other study(ies) available for 1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) and r-82913

ArticleYear
Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:9

    Topics: Antiviral Agents; Benzodiazepines; Drug Resistance, Microbial; HIV Reverse Transcriptase; Imidazoles; Macromolecular Substances; Mutation; Plasmids; Protein Conformation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Spiro Compounds; Substrate Specificity; Thymidine

1994